Back to Awarded Treatment Trials


Awarded Trial: 02T-269

Grant ID

02T-269

Illness

Schizophrenia Prodrome

Primary Drug/Intervention

Risperidone

Primary Dosage

0.5mg-1.0mg

Secondary Drug Intervention

Sertraline

Secondary Dosage

50mg-150mg

Other Drug/Intervention

N/A

Other Dosage

N/A

Status

Terminated

Investigator

Cornblatt

Sample Size

60

Duration of Study Period for Each Subject

16 weeks

Outcome Measurements

Scale of Prodromal Symptoms (SOPS), Children's Depression Inventory, Beck Depression Inventory, quality of life, global assessment of functioning, cognitive battery

Results

Terminated by the principal investigator, as a sufficient number of subjects could not be enrolled.

Publication

N/A

Link

N/A

PI Name

Barbara Cornblatt

Degree

PhD

Center

N/A

Institution

Zucker - Hillside Hospital

Address

A Division of Long Island Jewish Medical Center, 75-59 263rd Street

City or Town

Glen Oaks

State or Province

NY

Zip or Postal Code

11004

Country

USA

Email Address

cornblat@lij.edu